Implantation or Injectable Dosage Form New Animal Drugs; Sometribove Zinc Suspension
other · Food and Drug Administration · Rule · Published 2002-04-15 · Effective 2002-04-15 · 67 FR 18085
Document
Document number
02-9015
Federal Register citation
67 FR 18085
CFR reference
21 CFR 522
Type
Rule
Action
Final rule.
Category
other
Sub-agency
Food and Drug Administration
Publication date
2002-04-15
Effective date
2002-04-15
Abstract
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Monsanto Co. which provides for subcutaneous injection of sometribove zinc suspension in healthy lactating dairy cows to increase the production of marketable milk with no restriction on injection site. Three injection sites are recommended.